Sinocelltech Group Limited

Shanghai Stock Exchange 688520.SS

Sinocelltech Group Limited Free Cash Flow for the year ending December 31, 2023: USD -125.18 M

Sinocelltech Group Limited Free Cash Flow is USD -125.18 M for the year ending December 31, 2023, a 12.10% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Sinocelltech Group Limited Free Cash Flow for the year ending December 31, 2022 was USD -142.40 M, a 14.37% change year over year.
Sinocelltech Group Limited Free Cash Flow for the year ending December 31, 2021 was USD -166.30 M, a -65.81% change year over year.
Sinocelltech Group Limited Free Cash Flow for the year ending December 31, 2020 was USD -100.30 M, a -13.85% change year over year.
Sinocelltech Group Limited Free Cash Flow for the year ending December 31, 2019 was USD -88.10 M, a -217.72% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

Shanghai Stock Exchange: 688520.SS

Sinocelltech Group Limited

CEO	Dr. Liangzhi Xie Ph.D.
IPO Date	June 22, 2020
Location	China
Headquarters	No. 31 Kechuang 7th Street
Employees	2,313
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

Sinocelltech Group Limited, a biotech company, focuses on the development of technologies for the development and manufacturing of recombinant proteins, monoclonal antibodies, and vaccines in China. The company is based in Beijing, China.

Key trends

Past 5 years